Example: Heart Attack

Clinical Trials Sponsored by MedImmune Ltd

Total 9 results

  • NCT01714726
    Completed
    Evaluation of Efficacy and Safety of MEDI2070 in Patients With Active, Moderate-to-severe Crohn's Disease.
    Conditions: Crohn's Disease
  • NCT01050998
    Completed
    A Study to Evaluate the Efficacy and Safety of CAM-3001 (Drug) in Subjects With Rheumatoid Arthritis
    Conditions: Rheumatoid Arthritis
  • NCT02277574
    Completed
    Assess Safety, Tolerability, Pharmacokinetics and Clinical Activity of AMP-110 in Subjects With Rheumatoid Arthritis
    Conditions: Rheumatoid Arthritis
  • NCT01238861
    Completed
    Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled Asthma
    Conditions: Asthma
  • NCT01878123
    Completed
    Study to Assess the Safety, Tolerability, and Pharmacokinetics of AMP-110 in Subjects With Rheumatoid Arthritis
    Conditions: Rheumatoid Arthritis
  • NCT01706926
    Completed
    A Study of Mavrilimumab in Subjects With Moderate-to-Severe Rheumatoid Arthritis
    Conditions: Rheumatoid Arthritis
  • NCT01482884
    Completed
    Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis
    Conditions: Ulcerative Colitis
  • NCT01093040
    Completed
    A Study to Assess the Safety and Immunogenicity of the Drug CAT-354 in Healthy Japanese Subjects
    Conditions: Healthy
  • NCT00771420
    Completed
    A Single Dose Study of the CAM-3001 in Patients With Rheumatoid Arthritis
    Conditions: Rheumatoid Arthritis

Medical Conditions

Sponsors and Collaborators

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations